Smith & Nephew (LON:SN) Shares Cross Above Two Hundred Day Moving Average - Here's What Happened

Shares of Smith & Nephew plc (LON:SN - Get Free Report) crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 1,049.11 ($13.41) and traded as high as GBX 1,080.50 ($13.81). Smith & Nephew shares last traded at GBX 1,075 ($13.74), with a volume of 1,097,949 shares traded.

Wall Street Analysts Forecast Growth

Separately, JPMorgan Chase & Co. reiterated an "overweight" rating and issued a GBX 1,180 ($15.08) price objective on shares of Smith & Nephew in a research note on Tuesday, January 14th.

Smith & Nephew Stock Performance

The firm has a 50-day simple moving average of GBX 1,074.41 and a two-hundred day simple moving average of GBX 1,043.69. The company has a current ratio of 2.51, a quick ratio of 0.84 and a debt-to-equity ratio of 70.22. The company has a market capitalization of £10.74 billion, a price-to-earnings ratio of 35.26, a price-to-earnings-growth ratio of 0.46 and a beta of 0.62.

Smith & Nephew Increases Dividend

The company also recently disclosed a dividend, which will be paid on Wednesday, May 28th. Investors of record on Thursday, March 27th will be issued a $0.23 dividend. The ex-dividend date is Thursday, March 27th. This represents a yield of 1.61%. This is an increase from Smith & Nephew's previous dividend of $0.14. Smith & Nephew's dividend payout ratio is currently 104.41%.

Insider Activity at Smith & Nephew

In other Smith & Nephew news, insider Sybella Stanley bought 3,810 shares of the stock in a transaction on Wednesday, March 26th. The shares were purchased at an average cost of GBX 1,101 ($14.07) per share, with a total value of £41,948.10 ($53,600.95). Insiders own 0.19% of the company's stock.

Smith & Nephew Company Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.